JYAMS PET Research & Development

JYAMS PET Research & Development is a Japanese biotechnology company specializing in the development, manufacturing, and clinical application of Positron Emission Tomography (PET) imaging technologies. Established as a venture from the University of Yamanashi, the company focuses on radiopharmaceutical research, particularly for the early detection of Alzheimer's disease and other neurodegenerative disorders. They provide comprehensive PET imaging services, including the production of specialized tracers like [11C]PiB and [18F]FDG, and support for large-scale clinical trials such as the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI). The company operates its own cyclotron and radiopharmaceutical production facilities to bridge academic innovation with clinical diagnostic practice in neurology and oncology.